These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7114924)

  • 21. Natural cytotoxicity in systemic lupus erythematosus: mechanisms of suppression by inhibitory serum factors.
    Sibbitt WL; Froelich CJ; Bankhurst AD
    Clin Exp Immunol; 1983 Aug; 53(2):363-70. PubMed ID: 6883808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of natural killing with antibody dependent cell mediated cytotoxicity in patients with systemic lupus erythematosus.
    Kozlowski SH; Hirsen DJ; Jackson EJ
    J Rheumatol; 1982; 9(1):59-62. PubMed ID: 7086780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Family study of natural killer cell activity in C1q-deficient patients with systemic lupus erythematosus-like syndrome: association between impaired natural killer cell function and C1q deficiency.
    Tóth J; Starsia Z; Buc M; Stefanovic J
    Immunobiology; 1989 Nov; 180(1):47-54. PubMed ID: 2625354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytotoxic antibodies to natural killer cells in systemic lupus erythematosus.
    Rook AH; Tsokos GC; Quinnan GV; Balow JE; Ramsey KM; Stocks N; Phelan MA; Djeu JY
    Clin Immunol Immunopathol; 1982 Aug; 24(2):179-85. PubMed ID: 6981481
    [No Abstract]   [Full Text] [Related]  

  • 25. Abnormal natural killer cell activity in systemic lupus erythematosus: an intrinsic defect in the lytic event.
    Katz P; Zaytoun AM; Lee JH; Panush RS; Longley S
    J Immunol; 1982 Nov; 129(5):1966-71. PubMed ID: 7119439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural killer cells.
    Kay NE
    Crit Rev Clin Lab Sci; 1986; 22(4):343-59. PubMed ID: 2419034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the regulatory function of natural killer cells from patients with systemic lupus erythematosus.
    Cruz-González DJ; Gómez-Martin D; Layseca-Espinosa E; Baranda L; Abud-Mendoza C; Alcocer-Varela J; González-Amaro R; Monsiváis-Urenda AE
    Clin Exp Immunol; 2018 Mar; 191(3):288-300. PubMed ID: 29058308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormal macrophages and NK cell cytotoxicity in human systemic lupus erythematosus and the role of interferon and serum factors.
    Zippel D; Lackovic V; Kocisková D; Rovenský J; Borecký L; Stelzner A
    Acta Virol; 1989 Sep; 33(5):447-53. PubMed ID: 2483602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential expression of natural killer activating and inhibitory receptors in patients with newly diagnosed systemic lupus erythematosus.
    Ye Z; Ma N; Zhao L; Jiang ZY; Jiang YF
    Int J Rheum Dis; 2016 Jun; 19(6):613-21. PubMed ID: 24617980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of vitamin A treatment on the immune reactivity of patients with systemic lupus erythematosus.
    Vien CV; González-Cabello R; Bodó I; Gergely P
    J Clin Lab Immunol; 1988 May; 26(1):33-5. PubMed ID: 3184159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A killing defect of natural killer cells as an underlying immunologic abnormality in childhood systemic lupus erythematosus.
    Yabuhara A; Yang FC; Nakazawa T; Iwasaki Y; Mori T; Koike K; Kawai H; Komiyama A
    J Rheumatol; 1996 Jan; 23(1):171-7. PubMed ID: 8838528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural killer cells and the pathogenesis of systemic lupus erythematosus.
    Schattner A; Duggan DB
    Arthritis Rheum; 1984 Sep; 27(9):1072-3. PubMed ID: 6477659
    [No Abstract]   [Full Text] [Related]  

  • 33. Interferon and natural killer cells in systemic lupus erythematosus.
    Strannegård O; Hermodsson S; Westberg G
    Clin Exp Immunol; 1982 Nov; 50(2):246-52. PubMed ID: 6185256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-regulation of natural killer cells and of gamma/delta T cells in systemic lupus erythematosus. Does it correlate to autoimmunity and to laboratory indices of disease activity?
    Riccieri V; Spadaro A; Parisi G; Taccari E; Moretti T; Bernardini G; Favaroni M; Strom R
    Lupus; 2000; 9(5):333-7. PubMed ID: 10878724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural killer funciton in systemic lupus erythematosus.
    Hoffman T
    Arthritis Rheum; 1980 Jan; 23(1):30-5. PubMed ID: 7352941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural killer cells and interferon responses in patients with systemic lupus erythematosus.
    Tsokos GC; Rook AH; Djeu JY; Balow JE
    Clin Exp Immunol; 1982 Nov; 50(2):239-45. PubMed ID: 6817954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical significance of natural killer cell activity].
    Abo T
    Nihon Rinsho; 1990 Feb; 48 Suppl():726-9. PubMed ID: 2355603
    [No Abstract]   [Full Text] [Related]  

  • 38. Endogenous and interferon-augmented natural killer cell activity of human peripheral blood mononuclear cells in vitro. Studies of patients with multiple sclerosis, systemic lupus erythematosus or rheumatoid arthritis.
    Neighbour PA; Grayzel AI; Miller AE
    Clin Exp Immunol; 1982 Jul; 49(1):11-21. PubMed ID: 6181920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unraveling the expression of microRNA-27a* & NKG2D in peripheral blood mononuclear cells and natural killer cells of pediatric systemic lupus erythematosus patients.
    Sourour SK; Aboelenein HR; Elemam NM; Abdelhamid AK; Salah S; Abdelaziz AI
    Int J Rheum Dis; 2017 Sep; 20(9):1237-1246. PubMed ID: 28523761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus.
    Park YW; Kee SJ; Cho YN; Lee EH; Lee HY; Kim EM; Shin MH; Park JJ; Kim TJ; Lee SS; Yoo DH; Kang HS
    Arthritis Rheum; 2009 Jun; 60(6):1753-63. PubMed ID: 19479851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.